Core Viewpoint - The company reported significant growth in net profit for the first half of 2025, driven by strong sales in its agricultural pesticide business and effective cost management [1][2]. Financial Performance - In the first half of 2025, the company achieved operating revenue of 2.452 billion yuan, a year-on-year increase of 6.69% [1]. - The net profit attributable to shareholders reached 269 million yuan, reflecting a substantial year-on-year growth of 747.13% [1]. - In Q2 2025, the company recorded operating revenue of 1.241 billion yuan, a year-on-year decline of 5.10% but a quarter-on-quarter increase of 2.52% [1]. Business Segments - The agricultural fungicide segment generated revenue of 1.240 billion yuan in the first half of 2025, up 12.36% year-on-year, accounting for 50.57% of total revenue [2]. - The agricultural insecticide segment reported revenue of 748 million yuan, a year-on-year increase of 5.19%, representing 30.51% of total revenue [2]. - The company expanded its overseas market presence, with international revenue increasing by 22.42%, now comprising 34.57% of total revenue, up 4.44 percentage points from the previous year [2]. Cost Management and Cash Flow - The company maintained stable expenses, with sales, management, financial, and R&D expense ratios showing minor fluctuations [3]. - The net cash flow from operating activities for the first half of 2025 was 91.44 million yuan, a significant year-on-year increase of 180.08%, attributed to rising sales volumes, price increases, and improved gross margins [3]. Innovation and Market Development - The company has made substantial progress in the research and development of biopesticides, particularly in microbial synthesis technology [4]. - Collaborations with agricultural research institutions focus on green pest control technologies, enhancing the integration of AI in pesticide development and agricultural digitalization [4]. - The company has established a synthetic biology laboratory, strengthening its technical capabilities in the biopesticide sector [4]. Profit Forecast - The company forecasts net profits attributable to shareholders of 407 million yuan, 465 million yuan, and 584 million yuan for 2025, 2026, and 2027, respectively [5]. - The expected earnings per share (EPS) for the same years are projected to be 0.92 yuan, 1.05 yuan, and 1.32 yuan, with corresponding price-to-earnings (PE) ratios of 23.0, 20.1, and 16.0 [5].

Core Insights - The company reported a revenue of 4.507 billion yuan for the first half of 2025, representing a year-on-year growth of 35.36% [1] - The net profit reached 271 million yuan, showing a significant year-on-year increase of 191.21% [1] - The company plans to distribute a cash dividend of 2 yuan per 10 shares to all shareholders, including tax [1]

Investment Rating - The report maintains a "Buy" investment rating for the company [9] Core Views - The company's fungicide business shows steady growth, focusing on technological innovation and market expansion [5] - The company achieved a revenue of 2.452 billion yuan in the first half of 2025, representing a year-on-year increase of 6.69%, with a net profit of 269 million yuan, up 747.13% year-on-year [4] - The company is enhancing its competitiveness through a robust domestic and international market layout, with overseas market revenue increasing by 22.42% [5] Summary by Sections Market Performance - The company has maintained growth in sales of agricultural fungicides and insecticides, with fungicide revenue reaching 1.24 billion yuan, up 12.36% year-on-year, and insecticide revenue at 748 million yuan, up 5.19% year-on-year [5] Financial Performance - The company reported a significant increase in operating cash flow, with a net cash flow from operating activities of 91.44 million yuan, up 180.08% year-on-year [6] Technological Innovation - The company has made substantial progress in the field of biopesticides, particularly in microbial synthesis technology, enhancing its R&D capabilities and market responsiveness [7][8] - The establishment of a synthetic biology laboratory marks a significant advancement in the company's technological reserves in biopesticides [8] Profit Forecast - The company is projected to achieve net profits of 407 million yuan, 465 million yuan, and 584 million yuan for the years 2025, 2026, and 2027 respectively, with corresponding EPS of 0.92 yuan, 1.05 yuan, and 1.32 yuan [9][11]

Group 1: Financial Performance - In the first half of 2025, the company achieved total revenue of 6.531 billion yuan, a year-on-year increase of 14.94% [1] - The net profit attributable to shareholders reached 555.6 million yuan, up 205.62% year-on-year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 549 million yuan, an increase of 211.85% year-on-year [1] - In the second quarter of 2025, total revenue was 3.844 billion yuan, reflecting a year-on-year growth of 28.64% [1] - The net profit attributable to shareholders in Q2 2025 was 299 million yuan, a staggering increase of 932.30% year-on-year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses in Q2 2025 was 293 million yuan, up 1094.39% year-on-year [1] Group 2: Market Trends - The global crop protection market demand is expected to continue recovering, with low inventory levels in the pesticide overseas market [2] - The export quantity of crop protection products from January to June 2025 increased by 17.07% year-on-year, while the export value rose by 13.72% [2] - The demand for crop protection products remains strong, with a gradual recovery in gross margins across most end markets as supply-side costs decrease [2] Group 3: Strategic Initiatives - The company aims to become a leading global crop protection company, with four growth strategies being implemented [3] - The proportion of ToC (To Consumer) business increased to 40.14% in 1H25, with a gross margin of 30.21% [3] - Revenue from the EU and North America increased to 14.08% in 1H25 [3] - The company's insecticide and fungicide business revenue share rose to 26.59% in 1H25 [3] - The company is expanding its biopesticide segment, launching Rainbow Bio in more countries across Africa, Asia, and the Americas [3] - The company has obtained over 600 new registrations, totaling more than 8,400 pesticide registrations domestically and internationally as of June 30, 2025 [3] Group 4: Investment Outlook - The company is expected to benefit from its global registration layout and ToC channel development, leading to profit growth [3] - Projected net profits for 2025-2027 are 1.175 billion yuan, 1.417 billion yuan, and 1.748 billion yuan, with year-on-year growth rates of 161.01%, 20.58%, and 23.40% respectively [3] - Corresponding PE ratios are projected at 16X, 14X, and 11X for the respective years [4]

Core Viewpoint - The company reported a steady performance in the first half of 2025, with revenue and net profit showing moderate growth, while the global crop protection market is expected to recover, benefiting the company’s position as a leading player in the pesticide industry [1][2][3]. Financial Performance - In 1H25, the company achieved total revenue of 6.234 billion yuan, a year-on-year increase of 9.38% - The net profit attributable to shareholders was 806 million yuan, up 5.60% year-on-year - The non-recurring net profit was 796 million yuan, reflecting a 7.86% increase year-on-year - In Q2 2025, total revenue reached 2.993 billion yuan, a year-on-year increase of 18.63% - The net profit attributable to shareholders for Q2 was 371 million yuan, up 11.06% year-on-year [1]. Product Performance - The average selling price of raw materials in 1H25 was 64,500 yuan/ton, down 3.04% year-on-year, with sales volume at 56,700 tons, an increase of 13.4% - The average selling price of formulations was 41,600 yuan/ton, down 2.89% year-on-year, with sales volume at 28,100 tons, a slight increase of 0.1% - The company’s main products, including various pesticides, showed mixed price trends, with some products experiencing price declines while others saw increases [1]. Market Outlook - The global crop protection market is expected to see a continued recovery, with low inventory levels in overseas markets and stable demand for crop protection products - Export quantities for crop protection products increased by 17.07% year-on-year in the first half of 2025, with export value rising by 13.72% [2]. - The company, as a leading player in the pesticide industry, is well-positioned to benefit from this market recovery [2]. Project Development - The Youchuang project is progressing steadily, with the first phase of the Liaoning Youchuang project achieving design capacity - The project is included in China Sinochem's "14th Five-Year Plan" and is expected to generate significant revenue growth, with projected annual revenue of 1.5 billion yuan by 2026 and 4 billion yuan by 2030 [3]. - The project aims to resolve bottlenecks faced by the subsidiary Shenyang Kexin and optimize the company's production layout, enhancing its competitive position [3]. Investment Perspective - The company is expected to benefit from the recovery in the pesticide industry, with projected net profits of 1.34 billion yuan, 1.52 billion yuan, and 1.74 billion yuan for 2025-2027, reflecting year-on-year growth rates of 11.62%, 13.65%, and 13.86% respectively [3].

Core Viewpoint - The stock of Beishimei experienced a decline of 2.02% on August 27, with a trading price of 11.17 yuan per share and a total market capitalization of 4.034 billion yuan, indicating a mixed performance in recent trading sessions [1]. Financial Performance - For the first half of 2025, Beishimei achieved operating revenue of 776 million yuan, representing a year-on-year growth of 16.57%. The net profit attributable to shareholders was 34.706 million yuan, showing a significant increase of 109.70% compared to the previous period [2]. - Since its A-share listing, Beishimei has distributed a total of 62.87 million yuan in dividends, with 38.52 million yuan distributed over the past three years [3]. Stock Market Activity - As of August 27, Beishimei's stock price has increased by 9.40% year-to-date, but it has seen a decline of 6.92% over the last five trading days. In the last 20 days, the stock rose by 3.71%, and in the last 60 days, it increased by 3.81% [1]. - The stock's trading volume on August 27 was 131 million yuan, with a turnover rate of 3.20%. The net outflow of main funds was 16.33 million yuan, with significant selling pressure observed [1]. Company Overview - Beishimei, established on March 31, 2003, and listed on November 15, 2019, is located in Shaoxing, Zhejiang Province. The company specializes in the research, production, and sales of various chemical products, primarily focusing on 4-nitro intermediates, dimethenamid-p active ingredients, and formulations [1]. - The revenue composition of Beishimei includes 25.95% from dimethenamid-p active ingredients, 25.54% from trade herbicides, 18.91% from trade insecticides, and other chemical products [1]. Shareholder Information - As of June 30, Beishimei had 19,900 shareholders, an increase of 82.96% from the previous period. The average number of tradable shares per shareholder decreased by 45.34% to 18,160 shares [2].

Core Viewpoint - Yangnong Chemical has shown significant stock performance with a year-to-date increase of 29.92% and a recent 5-day increase of 13.44% [1] Group 1: Stock Performance - As of August 27, Yangnong Chemical's stock price rose by 2.12% to 74.30 CNY per share, with a trading volume of 1.41 billion CNY and a turnover rate of 0.48%, resulting in a total market capitalization of 30.121 billion CNY [1] - The stock has experienced a 31.69% increase over the past 60 days [1] Group 2: Financial Performance - For the first half of 2025, Yangnong Chemical reported a revenue of 6.234 billion CNY, representing a year-on-year growth of 9.38%, and a net profit attributable to shareholders of 806 million CNY, up 5.60% year-on-year [2] Group 3: Shareholder Information - As of June 30, 2025, the number of shareholders decreased by 6.01% to 18,100, while the average circulating shares per person increased by 6.40% to 22,271 shares [2] - The company has distributed a total of 2.735 billion CNY in dividends since its A-share listing, with 1.04 billion CNY distributed in the last three years [2] Group 4: Major Shareholders - As of June 30, 2025, Hong Kong Central Clearing Limited is the fourth-largest shareholder with 16.2928 million shares, an increase of 754,800 shares from the previous period [2] - Other notable shareholders include E Fund Yufeng Return Bond A and E Fund New Income Mixed A, with changes in their holdings compared to the previous period [2]

Financial Performance - The company reported a total operating revenue of 591 million yuan, an increase of 52.29 million yuan compared to the same period last year, achieving a year-on-year growth of 9.70% [1] - The net profit attributable to shareholders reached 90.59 million yuan, marking an increase of 22.39 million yuan from the previous year, with a year-on-year growth of 32.84% [1] - The net cash inflow from operating activities was 82.57 million yuan [1] Key Financial Ratios - The latest debt-to-asset ratio stands at 27.10%, ranking 7th among disclosed peers [3] - The gross profit margin is 35.37%, ranking 3rd among disclosed peers, with an increase of 2.30 percentage points from the previous quarter and a year-on-year increase of 3.92 percentage points [3] - The return on equity (ROE) is 7.44%, ranking 10th among disclosed peers, with a year-on-year increase of 1.59 percentage points [3] - The diluted earnings per share (EPS) is 0.58 yuan, ranking 11th among disclosed peers, with a year-on-year increase of 31.82% [3] - The total asset turnover ratio is 0.36 times, ranking 15th among disclosed peers, with a year-on-year increase of 1.41% [3] - The inventory turnover ratio is 3.25 times, ranking 10th among disclosed peers [3] Shareholder Information - The number of shareholders is 7,818, with the top ten shareholders holding a total of 115 million shares, accounting for 73.59% of the total share capital [3] - The largest shareholder is Zhejiang Xinhui Investment Co., Ltd., holding 54.5 million shares [3]

Core Viewpoint - Glyphosate has experienced a turnaround after three years of low performance, with prices rising from 22,000 yuan to 26,000 yuan per ton, marking an increase of nearly 20% [1] Group 1: Price and Demand Dynamics - The price of glyphosate has significantly increased due to low industry inventory and the traditional export peak season to South America from June to August, leading to tight market supply [2] - Glyphosate's demand is heavily reliant on exports, with 70% of its demand coming from international markets, particularly during the procurement season in South America [2] - The export volume of glyphosate in the first half of the year reached 331,000 tons, a year-on-year increase of 14.2%, while the export value was $970 million, up 11.1% year-on-year [2] Group 2: Supply Chain and Cost Factors - The production of glyphosate is constrained by strict policies on yellow phosphorus capacity and energy consumption, leading to price fluctuations [3] - The average price of yellow phosphorus in the first half of the year was 23,300 yuan, an increase of 464 yuan compared to the average price in 2024 [3] - There has been no new production capacity added in the glyphosate industry from 2018 to the first half of 2025, with effective domestic capacity expected to stabilize around 800,000 tons [3] Group 3: Future Price Trends - Glyphosate prices are expected to continue rising due to strong order intake from major companies and low inventory pressure [4] - The market demand for glyphosate is projected to grow with the expansion of genetically modified crop planting and the banning of alternative herbicides [4] - The industry is likely to see an improvement in supply-demand structure, with leading domestic companies potentially increasing their market share due to uncertainties in Monsanto's production capacity [4]

上市企业：扬农化工（600486）,安道麦Ａ（000553）,先达股份（603086）,ST红太阳（000525）,诺普 信（002215）,利尔化学（002258）,润丰股份（301035）,新安股份（600596） 数据来源：国家统计局，智研咨询整理 相关报告：智研咨询发布的《2025-2031年中国农药行业市场全景调研及前景战略研判报告》 根据国家统计局数据显示：2025年6月中国化学农药原药(折有效成分100％)产量为37.1万吨，同比增长 10.4%；2025年1-6月中国化学农药原药(折有效成分100％)累计产量为208.5万吨，累计增长9.7%。 2020-2025年上半年中国化学农药原药(折有效成分100％)产量统计图 知前沿，问智研。智研咨询是中国一流产业咨询机构，十数年持续深耕产业研究领域，提供深度产业研 究报告、商业计划书、可行性研究报告及定制服务等一站式产业咨询服务。专业的角度、品质化的服 务、敏锐的市场洞察力，专注于提供完善的产业解决方案，为您的投资决策赋能。 ...